Yvonne Mc Grath I Teos Therapeutics, Inc. (ITOS) insider trading activity

Yvonne Mc Grath is Chief Scientific Officer of iTeos Therapeutics, Inc.. Currently has a direct ownership of 46,300 shares of ITOS, which is worth approximately $321,785. The most recent transaction as insider was on Mar 07, 2025, when has been sold 15,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.3K

49.35% 3M change

49.35% 12M change

Total Value Held $321,785

Yvonne McGrath Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2025	BUY Grant, award, or other acquisition	-	15,300 Added 24.84%	46,300 Common Stock
Dec 05 2023	BUY Grant, award, or other acquisition	-	31,000 Added 50.0%	31,000 Common Stock
Mar 01 2022	SELL Open market or private sale	$367,600 $36.76 p/Share	10,000 Reduced 100.0%	0 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	$42,400 $4.24 p/Share	10,000 Added 50.0%	10,000 Common Stock
Jun 08 2021	SELL Open market or private sale	$158,540 $20.0 p/Share	7,927 Reduced 100.0%	0 Common Stock
Jun 08 2021	BUY Exercise of conversion of derivative security	$33,531 $4.23 p/Share	7,927 Added 50.0%	7,927 Common Stock
Jun 02 2021	SELL Open market or private sale	$6,460 $20.0 p/Share	323 Reduced 100.0%	0 Common Stock
Jun 02 2021	BUY Exercise of conversion of derivative security	$1,366 $4.23 p/Share	323 Added 50.0%	323 Common Stock
Jun 01 2021	SELL Open market or private sale	$153,449 $20.18 p/Share	7,604 Reduced 100.0%	0 Common Stock
Jun 01 2021	BUY Exercise of conversion of derivative security	$32,165 $4.23 p/Share	7,604 Added 50.0%	7,604 Common Stock
May 24 2021	SELL Open market or private sale	$173,760 $21.92 p/Share	7,927 Reduced 100.0%	0 Common Stock
May 24 2021	BUY Exercise of conversion of derivative security	$33,531 $4.23 p/Share	7,927 Added 50.0%	7,927 Common Stock
May 17 2021	SELL Open market or private sale	$200,369 $25.28 p/Share	7,926 Reduced 100.0%	0 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	$33,527 $4.23 p/Share	7,926 Added 50.0%	7,926 Common Stock

Yvonne Mc Grath

Chief Scientific Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITOS shares.

Notify only if

Value

Insider Trading

Get notified when an I Teos Therapeutics, Inc. insider buys or sells ITOS shares.

Notify only if

Operation

Value

Type

News

Receive news related to iTeos Therapeutics, Inc.

Track Activities on ITOS

Account